Literature DB >> 22050456

Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.

Weidong Zhou1, Michela Capello, Claudia Fredolini, Leda Racanicchi, Lorenzo Piemonti, Lance A Liotta, Francesco Novelli, Emanuel F Petricoin.   

Abstract

In this present work, we characterized the proteomes of pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1 and normal pancreatic duct cells by mass spectrometry using LTQ-Orbitrap and identified more than 1700 proteins from each sample. On the basis of the spectra count label-free quantification approach, we identified a large number of differentially expressed metabolic enzymes and proteins involved in cytoskeleton, cell adhesion, transport, transcription, translation, and cell proliferation as well. The data demonstrated that metabolic pathways were altered in PANC-1, consistent with the Warburg effect. In addition, the comparative MS analysis unveiled anomalous metabolism of glutamine, suggesting that glutamine was largely consumed as a nitrogen donor in nucleotide and amino acid biosynthesis in PANC-1. Our analysis provides a potentially comprehensive picture of metabolism in PANC-1, which may serve as the basis of new diagnostics and treatment of PDAC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050456      PMCID: PMC5564318          DOI: 10.1021/pr2009274

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  43 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 2.  Lysosomes as targets for cancer therapy.

Authors:  Nicole Fehrenbacher; Marja Jäättelä
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

Review 4.  Proteomic profiling of pancreatic cancer for biomarker discovery.

Authors:  Ru Chen; Sheng Pan; Teresa A Brentnall; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2005-01-31       Impact factor: 5.911

Review 5.  Otto Warburg's contributions to current concepts of cancer metabolism.

Authors:  Willem H Koppenol; Patricia L Bounds; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

6.  Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations.

Authors:  Weidong Zhou; Michela Capello; Claudia Fredolini; Lorenzo Piemonti; Lance A Liotta; Francesco Novelli; Emanuel F Petricoin
Journal:  J Proteome Res       Date:  2011-02-28       Impact factor: 4.466

7.  An essential role for p300/CBP in the cellular response to hypoxia.

Authors:  Z Arany; L E Huang; R Eckner; S Bhattacharya; C Jiang; M A Goldberg; H F Bunn; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

9.  Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Purna Mukherjee; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2010-07-23       Impact factor: 4.146

10.  The expression of selenium-binding protein 1 is decreased in uterine leiomyoma.

Authors:  Peng Zhang; Cunxian Zhang; Xudong Wang; Fang Liu; C James Sung; M Ruhul Quddus; W Dwayne Lawrence
Journal:  Diagn Pathol       Date:  2010-12-09       Impact factor: 2.644

View more
  38 in total

Review 1.  The spectra count label-free quantitation in cancer proteomics.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012 May-Jun       Impact factor: 4.069

Review 2.  Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.

Authors:  Xi Hu; Fan Xia; Jiyoung Lee; Fangyuan Li; Xiaoyang Lu; Xiaozhen Zhuo; Guangjun Nie; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-12       Impact factor: 16.806

Review 3.  The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

4.  Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.

Authors:  Wenwen Chien; Qiao-Yang Sun; Kian Leong Lee; Ling-Wen Ding; Peer Wuensche; Lucia A Torres-Fernandez; Siew Zhuan Tan; Itay Tokatly; Norazean Zaiden; Lorenz Poellinger; Seiichi Mori; Henry Yang; Jeffrey W Tyner; H Phillip Koeffler
Journal:  Mol Oncol       Date:  2015-01-15       Impact factor: 6.603

Review 5.  Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012-11       Impact factor: 4.069

Review 6.  Energy metabolism and proliferation in pancreatic carcinogenesis.

Authors:  Ivonne Regel; Bo Kong; Susanne Raulefs; Mert Erkan; Christoph W Michalski; Mark Hartel; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2012-03-20       Impact factor: 3.445

Review 7.  Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Authors:  Shiro Urayama
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 8.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

9.  A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.

Authors:  Núria Buil-Bruna; José-María López-Picazo; Marta Moreno-Jiménez; Salvador Martín-Algarra; Benjamin Ribba; Iñaki F Trocóniz
Journal:  AAPS J       Date:  2014-04-17       Impact factor: 4.009

10.  Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.

Authors:  Fang Peng; Ying Huang; Mao-Yu Li; Guo-Qing Li; Hui-Chao Huang; Rui Guan; Zhu-Chu Chen; Song-Ping Liang; Yong-Heng Chen
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.